Developed with support from Health Canada
Medication incidents are a leading cause of preventable adverse events. Drug name confusion, particularly because of look-alike/sound-alike (LASA) name attributes, can be a contributing factor to medication related adverse events.
TALLman lettering is a method of applying upper-case lettering to sections of LASA drug names as a differentiation strategy.
Canadian TALLman Lettering List Principles for the Application of TALLman Lettering (Revised March 2016) TALLman Lettering Bulletin TALLman Lettering Project Report
|Copyright © 2000-2021 Institute for Safe Medication Practices Canada (ISMP Canada). All Rights Reserved. Privacy. Disclaimer.|